Robert Fallon is CEO and Co-founder of Phosplatin Therapeutics, a clinical stage biotech company currently conducting three Phase II trials with plans to launch a pivotal Phase III trial in 2021.
Mr. Fallon is a highly respected leader with decades of global transactional and strategic leadership.
Mr. Fallon is a highly respected leader with decades of global transactional and strategic leadership.
Speaking In
[Available On-Demand]
Phosplatin Therapeutics is a privately held, clinical stage pharmaceutical company. Its lead…